semaglutide in tampa oral Novo Nordisk's Ozempic® pill, the only FDA-approved peptide GLP-1 medication for adults with type 2 diabetes, soon to be available the US The 2026 Brandon GLP-1 Report: – Padgett Medical Center | Medical

Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use.

Anticipated improvements post-treatment may include a gradual lightening of the skin, reduction in blemishes or spots, and an overall clearer complexion

In a phase II trialExternal link, the medication, injected once a week, met its primary endpoint of statistically significant weight loss

However, challenges such as short-lived effects and the development of nitrate tolerance and endothelial dysfunction have limited their efficacy (Rapoport et al., 1987

Scherer cares for patients living with rare obesity syndromes and recounts a recent particular struggle to treat two male patients ages 20 and 23 years with AS, who did not respond to multimodal obesity therapy including GLP-1RAs